Data gathered: April 15
AI Stock Analysis - Vericel (VCEL)
Analysis generated May 28, 2024. Powered by Chat GPT.
Vericel Corporation is a biotech company that focuses on advanced therapies for the treatment of sports injuries and conditions involving cartilage repair. The company is dedicated to improving patient outcomes, particularly through the development and commercialization of significant therapies. Vericel's flagship products include MACI (a cartilage repair therapy) and Epicel (a treatment for severe burn patients).
Stock Alerts - Vericel (VCEL)
 |
Vericel | April 10 Price is down by -5.1% in the last 24h. |
|
Vericel | April 9 Price is up by 5.3% in the last 24h. |
|
Vericel | April 8 Price is down by -5.1% in the last 24h. |
|
Vericel | April 7 Price is down by -5.9% in the last 24h. |
Alternative Data for Vericel
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 17 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 29 | Sign up | Sign up | Sign up |
| Patents | 4 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 458 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 13 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 8,210 | Sign up | Sign up | Sign up |
| Twitter Followers | 889 | Sign up | Sign up | Sign up |
| Twitter Mentions | 8 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 51 | Sign up | Sign up | Sign up |
| Linkedin Employees | 390 | Sign up | Sign up | Sign up |
About Vericel
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States.
| Price | $41.23 |
| Target Price | Sign up |
| Volume | 537,440 |
| Market Cap | $2.07B |
| Year Range | $38.6 - $61.8 |
| Dividend Yield | 0% |
| PE Ratio | 206.25 |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
LPL Financial LLC Has $3.27 Million Stock Position in Vericel Co. (NASDAQ:VCEL)April 12 - ETF Daily News |
 |
Vericel price target lowered by $10 at Truist, here's whyApril 11 - Thefly.com |
|
Analyzing Neumora Therapeutics (NASDAQ:NMRA) & Vericel (NASDAQ:VCEL)April 6 - ETF Daily News |
|
Orion Portfolio Solutions LLC Has $997,000 Stake in Vericel Co. (NASDAQ:VCEL)April 6 - ETF Daily News |
|
Vericel Co. (NASDAQ:VCEL) Shares Sold by Sei Investments Co.April 4 - ETF Daily News |
|
Vericel Co. (NASDAQ:VCEL) Stake Reduced by Corebridge Financial Inc.April 4 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 58M | 16M | 42M | -900,000 | 580,000 | -0.020 |
| Q2 '24 | 53M | 16M | 37M | -4.7M | -3.2M | -0.100 |
| Q1 '24 | 51M | 16M | 35M | -3.9M | -2.3M | -0.080 |
| Q4 '23 | 65M | 16M | 49M | 13M | 15M | 0.260 |
| Q3 '23 | 46M | 15M | 31M | -3.7M | -2.6M | -0.080 |
Insider Transactions View All
| Colangelo Dominick filed to sell 259,997 shares at $45.8. March 14 '25 |
| Colangelo Dominick filed to sell 259,997 shares at $46.3. March 14 '25 |
| Mara Joseph Anthony Jr filed to sell 13,967 shares at $49.5. March 5 '25 |
| Hagen Heidi filed to sell 28,650 shares at $49.5. March 5 '25 |
| Hopper Jonathan Mark filed to sell 66,101 shares at $49.5. March 5 '25 |
Similar companies
Read more about Vericel (VCEL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Vericel?
The Market Cap of Vericel is $2.07B.
What is Vericel's PE Ratio?
As of today, Vericel's PE (Price to Earnings) ratio is 206.25.
What is the current stock price of Vericel?
Currently, the price of one share of Vericel stock is $41.23.
How can I analyze the VCEL stock price chart for investment decisions?
The VCEL stock price chart above provides a comprehensive visual representation of Vericel's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Vericel shares. Our platform offers an up-to-date VCEL stock price chart, along with technical data analysis and alternative data insights.
Does VCEL offer dividends to its shareholders?
As of our latest update, Vericel (VCEL) does not offer dividends to its shareholders. Investors interested in Vericel should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Vericel?
Some of the similar stocks of Vericel are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.